Federico Cavanna

Researcher in psychedelic science / neuroscientific researcher (exact current title not confidently verified)

Data updated

Papers

8 publications

Trials

0 clinical trials

Research Footprint

Federico Cavanna appears in 8 tracked papers (2021–2025), most studied alongside Psilocybin, DMT and Placebo, across Neuroimaging & Brain Measures, Microdosing and Creativity.

Most-cited paper: Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study (127 citations).

Frequent co-authors: Enzo Tagliazucchi, Claudio Pallavicini and Laura Alethia de la Fuente.

Background & Research

Federico Cavanna appears as an author on several psychedelic-science papers, including controlled studies of psilocybin microdosing and work on DMT-induced mystical-type experiences. The publications associated with this name suggest a research focus at the intersection of psychopharmacology, neuroscience, and cognition, with a strong emphasis on naturalistic and experimental psychedelic use.

Key Impact

He is a coauthor on multiple widely cited studies on psilocybin microdosing, DMT, and psychedelic use, helping characterize subjective, behavioral, and cognitive effects of psychedelics.

8

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

10 collaborators· click a node to visit their profile

Full network →

Affiliations

Institutions, companies, and organisations Federico Cavanna is associated with.